Anaplastic lymphoma kinase: a glimmer of hope in lung cancer treatment?

Author： Franco Renato   Rocco Gaetano   Marino Federica Zito   Pirozzi Giuseppe   Normanno Nicola   Morabito Alessandro   Sperlongano Pasquale   Stiuso Paola   Luce Amalia   Botti Gerardo   Caraglia Michele  

Publisher： Informa Healthcare

ISSN： 1473-7140

Source： Expert Review of Anticancer Therapy, Vol.13, Iss.4, 2013-04, pp. : 407-420

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anaplastic Lymphoma Kinase as a Therapeutic Target in Anaplastic Large Cell Lymphoma, Non-Small Cell Lung Cancer and Neuroblastoma

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 3, 2010-03 ,pp. : 236-249

Bentham Science Publishers

Access to resources Recommend Favorite

Can Patients' Likelihood of Benefiting from Primary Chemotherapy for Breast Cancer Be Predicted Before Commencement of Treatment?

By Ogston Keith   Miller Iain   Schofield Andrew   Spyrantis Andreas   Pavlidou Eleni   Sarkar Tarun   Hutcheon Andrew   Payne Simon   Heys Steven  

Breast Cancer Research and Treatment, Vol. 86, Iss. 2, 2004-07 ,pp. : 181-189

Springer Publishing Company

Access to resources Recommend Favorite

Interim positron emission tomography in early stage Hodgkin lymphoma: is there evidence for its prognostic and predictive value in patients treated with standard combined modality treatment?

By Specht Lena  

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1127-1128

Informa Healthcare

Access to resources Recommend Favorite

Diagnostic and therapeutic issues for patients with advanced nonsmall cell lung cancer harboring anaplastic lymphoma kinase rearrangement: European vs. US perspective (Review)

By        

International Journal of Oncology, Vol. 45, Iss. 2, 2014-01 ,pp. : 509-515

Spandidos Publications

Access to resources Recommend Favorite

Response to alectinib after one year of discontinuation of crizotinib in anaplastic lymphoma kinase-positive non-small-cell lung cancer: A case report

By                  

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 889-891

Science Publishers

Access to resources Recommend Favorite